Multicenter Canadian phase III randomized trial of 3 months vs 8 months neoadjuvant androgen deprivation prior to conventional dose radiotherapy for clinically localized prostate cancer

被引:0
|
作者
Crook, JM
Ludgate, C
Lim, J
Malone, S
Eapen, L
Perry, G
Bowen, J
Robertson, S
Lockwood, G
机构
来源
JOURNAL OF UROLOGY | 2004年 / 171卷 / 04期
关键词
D O I
10.1016/S0022-5347(18)38419-2
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:312 / 312
页数:1
相关论文
共 50 条
  • [31] Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate - A randomized controlled trial
    Zietman, AL
    DeSilvio, ML
    Slater, JD
    Rossi, CJ
    Miller, DW
    Adams, JA
    Shipley, WU
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (10): : 1233 - 1239
  • [32] Moderate hypofractionated radiotherapy vs conventional fractionated radiotherapy in localized prostate cancer: a systemic review and meta-analysis from Phase III randomized trials
    Yin, Zhenzhen
    You, Jinqiang
    Wang, Youyou
    Zhao, Jinlin
    Jiang, Shengpeng
    Zhang, Ximei
    Wang, Peiguo
    Tao, Zhen
    Wang, Xin
    Yuan, Zhiyong
    ONCOTARGETS AND THERAPY, 2019, 12 : 1259 - 1268
  • [33] Re: High-risk Prostate Cancer Treated with Pelvic Radiotherapy and 36 Versus 18 Months of Androgen Blockade: Results of a Phase III Randomized Study [Abstract 3]
    Bolla, Michel
    EUROPEAN UROLOGY, 2013, 64 (03) : 513 - 513
  • [34] Reply to comment on: Androgen deprivation therapy and radiotherapy in intermediate-risk prostate cancer: A randomised phase III trial
    Nabid, Abdenour
    Souhami, Luis
    EUROPEAN JOURNAL OF CANCER, 2022, 167 : 166 - 167
  • [35] Phase II trial of external radiotherapy, brachytherapy, androgen deprivation and docetaxel chemotherapy for high-risk, localized prostate cancer
    DiBiase, SJ
    Dawson, N
    Kwok, Y
    Kataria, R
    Hussain, A
    Nagda, S
    Bangalore, M
    Amin, P
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S296 - S297
  • [36] The Relationship Between Hot Flashes and Testosterone Recovery Following 12 Months of Androgen Suppression for Men With Localized Prostate Cancer in a Randomized Trial
    Dosani, M.
    Morris, J.
    Tyldesley, S.
    Pickles, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S126 - S126
  • [37] A Multicenter Randomized Trial of Ibandronate Compared With Single-Dose Radiotherapy for Localized Metastatic Bone Pain in Prostate Cancer
    Hoskin, Peter
    Sundar, Santhanam
    Reczko, Krystyna
    Forsyth, Sharon
    Mithal, Natasha
    Sizer, Bruce
    Bloomfield, David
    Upadhyay, Sunil
    Wilson, Paula
    Kirkwood, Amy
    Stratford, Michael
    Jitlal, Mark
    Hackshaw, Allan
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (10):
  • [38] Randomized comparative study of 3 vs 8 months of neoadjuvant hormonal therapy prior to radical prostatectomy: 3 year PSA recurrence rates
    Gleave, ME
    Goldenberg, L
    Chin, JL
    Warner, J
    Saad, F
    Klotz, L
    Jewett, M
    Kassabian, V
    Chetner, M
    Dupont, C
    JOURNAL OF UROLOGY, 2003, 169 (04): : 179 - 179
  • [39] A Phase III Randomized Study of High-dose Conventional vs. Hypofractionated Radiotherapy in Patients with High-risk Prostate Cancer
    Arcangeli, G.
    Saracino, B.
    Gomellini, S.
    Petrongari, M.
    Arcangeli, S.
    Sentinelli, S.
    Strigari, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S79 - S80
  • [40] A Phase II, Randomized, Multicenter Study Comparing 10 Months versus 4 Months of Degarelix Therapy in Prolonging the Off Treatment Interval in Men with Localized Prostate Cancer Receiving Intermittent Androgen Deprivation Therapy for Biochemical Recurrence following Radical Local Therapy
    Klotz, Laurence
    Loblaw, Andrew
    Siemens, Robert
    Ouellette, Paul
    Kapoor, Anil
    Kebabdjian, Marlene
    Zhang, Liying
    Saad, Fred
    JOURNAL OF UROLOGY, 2018, 200 (02): : 335 - 342